[뉴스토마토 박재연 기자] To revolutionize the field of autism diagnosis and treatment, the Our Children Foundation, Tomato Chain, iTomato Oriental Hospital, and a privately held AI development startup have joined forces to launch the Autism Diagnosis AI Project Consortium. The four organizations are prominent in their respective fields and plan to work together to revolutionize the early diagnosis and treatment of autism spectrum disorder (ASD).
Our Children Foundation is a non-profit organization that aims to support children with autism and their families. Tomato Chain is an affiliate of Tomato Group based on blockchain technology, providing a secure and transparent data management system. iTomato Oriental Hospital is a specialized hospital of Dr. Kim Moon-ju(picture), the top authority on autism in Korea, who first proved the possibility of treating autism, and is contributing to improving the quality of life of autistic children through oriental medicine treatment. Finally, an undisclosed AI company is a startup that specializes in AI development and plans to provide AI model-related technologies.
The consortium will issue a new token based on TTCHAIN to support the autism diagnosis and treatment project by implementing talkonomics. This is expected to provide more efficient and convenient services for patients and families, and contribute to reducing the financial burden of autism diagnosis and treatment.
In addition, if any profits are generated from the donation, diagnosis, and treatment process, they will be returned in full.
The core of the project is to support the entire process from early diagnosis to treatment support through the combination of AI and blockchain technology. AI technology is used to develop an early diagnosis model for children with autism based on the research of Dr. Moonju Kim of iTomato Oriental Hospital using deep learning, and blockchain is used to enhance the security and transparency of patient data. This will provide customized treatment plans for children with autism and their families, and is expected to play a major role in improving the quality of life of children with autism. The launch of this consortium is a revolutionary step forward in the field of autism diagnosis and treatment. Through the combination of cutting-edge technology and multi-institutional collaboration, it is expected to make a positive difference in the lives of children with autism spectrum disorders and their families. By combining the expertise and resources of each organization, the consortiums efforts to improve the autism diagnosis and treatment process are particularly focused on early detection and treatment of autism spectrum disorders. Early diagnosis enables children with autism to reach their full potential, and with the right treatment and support, they can become more socially adapted.
The AI-based diagnostic system to be developed through this collaboration will analyze data from various aspects of autistic childrens language, behavior, and social interactions to provide personalized diagnostic information. The data will be securely managed using blockchain technology, and will also support the development of new drugs that can dramatically help treat autism and ADHD.
This consortium represents a new model for autism diagnosis and treatment that combines technological advances with a human approach. In doing so, we are making breakthroughs to address the challenges faced by children with autism and their families and improve their
quality of life. The success of this consortium is raising expectations for innovative approaches not only in the field of autism diagnosis and treatment, but also in many other areas of healthcare.
박재연 기자 damgomi@etomato.com
ⓒ 맛있는 뉴스토마토, 무단 전재 - 재배포 금지